Skip to content

Based on my thorough review of the GO-CAM model "Ufmylation pathway (Human)" (gomodel:65f3ae5c00000111) and the supporting scientific literature, I can now provide a comprehensive assessment.

GO-CAM Review: Ufmylation pathway (Human)

Summary

This GO-CAM model describes the Ufmylation pathway in humans, which is a post-translational modification pathway involving the ubiquitin-fold modifier 1 (UFM1). The model correctly represents the key components and causal relationships in this pathway, capturing the enzymatic cascade that leads to protein UFMylation.

Overall Assessment

The model represents a well-constructed and evidence-supported representation of the UFMylation pathway. It accurately captures the functional roles of the four key proteins in this pathway and their causal relationships, with appropriate literature citations and evidence codes.

Strengths

  1. Comprehensive representation: The model includes all the key components of the UFMylation pathway: UBA5 (E1 activating enzyme), UFC1 (E2 conjugating enzyme), UFL1 (E3 ligase), and UFSP1 (UFM1-specific protease).

  2. Appropriate causal relationships: The model correctly represents the causal flow from protein maturation through the enzymatic cascade using the "provides input for" (RO:0002413) predicate.

  3. Strong evidence base: Each association in the model is supported by appropriate evidence, with multiple recent publications (2020-2024) cited. This reflects the current understanding of the pathway.

  4. Cellular localization: The model correctly indicates that UFSP1 activity occurs in the cytosol (GO:0005829), which is consistent with the literature.

  5. Correct molecular functions: Each protein is assigned the appropriate molecular function:

  6. UFSP1: cysteine-type peptidase activity (GO:0008234)
  7. UFL1: UFM1 ligase activity (GO:0061666)
  8. UFC1: UFM1 conjugating enzyme activity (GO:0061657)

  9. UBA5: UFM1 activating enzyme activity (GO:0071566)

  10. Up-to-date scientific knowledge: The model incorporates recent findings about UFSP1 (2022-2023), which corrected previous misconceptions about its catalytic activity.

Areas for Potential Improvement

  1. Additional cellular components: The model could be enhanced by including the cellular localization for UFL1, UFC1, and UBA5. According to the literature:
  2. UFL1 is primarily localized to the endoplasmic reticulum membrane
  3. UFC1 is distributed throughout the cell

  4. UBA5 is primarily cytosolic but can also be found in the nucleus and ER membrane

  5. Substrates of UFMylation: The model could potentially include the main substrate of this pathway, RPL26 (ribosomal protein L26), which is the principal target of UFMylation according to recent literature.

  6. Missing regulatory components: The model doesn't include DDRGK1 (also known as UFBP1) and CDK5RAP3, which are important additional components of the UFM1 E3 ligase complex that work with UFL1.

  7. Biological outcomes: The model could be extended to include the biological consequences of UFMylation, such as ribosome recycling from the ER translocon.

Technical Correctness

From a technical perspective, the model is correctly constructed according to GO-CAM standards:

  1. Each protein is appropriately linked to its molecular function via "enabled by" relations.
  2. The causal flow follows the standard "provides input for" (RO:0002413) predicate.
  3. All activities are indicated to be part of the broader biological process "protein ufmylation" (GO:0071569).
  4. UFSP1's activity is additionally indicated to be part of "protein maturation" (GO:0051604).
  5. Evidence codes are appropriate (ECO:0000314 for direct assay evidence, ECO:0000315 for mutant phenotype evidence).

Biological Accuracy

The model accurately represents the current understanding of the UFMylation pathway:

  1. UFSP1 is now recognized as an active protease that cleaves the C-terminal peptide of pro-UFM1 to generate mature UFM1 (based on 2022-2023 research).

  2. The enzymatic cascade follows the established order:

  3. UBA5 activates UFM1 in an ATP-dependent manner
  4. UFC1 accepts the activated UFM1 from UBA5

  5. UFL1 transfers UFM1 from UFC1 to target proteins

  6. The model correctly identifies that UFSP1 provides input for UBA5's activity through its role in maturing pro-UFM1.

Conclusion

This GO-CAM model provides an accurate and well-supported representation of the human UFMylation pathway. It correctly captures the enzymatic cascade, molecular functions, and causal relationships between the key components.

The model could be enhanced by including additional components (DDRGK1, CDK5RAP3), cellular locations for all proteins, and downstream biological consequences of UFMylation. Nevertheless, as it stands, the model represents a high-quality contribution to our understanding of post-translational modifications in human cells.